As HPV data stacks up, Merck touts Gardasil for boys

July 25, 2011 By Leave a Comment

Fierce Pharma July 21, 2011 — 10:29am ET | By Tracy Staton Merck’s ($MRK) Gardasil journey is becoming a saga, with twists and turns all over the place. When first approved, the vaccine against human papillomavirus was tagged as a no-brainer blockbuster. But uptake of the vaccine hit a snag; after about a third of eligible [...]

[Continue reading...]
Filed Under: Gardasil / Silgard, STD's, Vaccine Marketing, Vaccines and the Media Tagged With: , , , , ,

Buccal exposure to human papillomavirus type 16 is a common yet transitory event of childhood

June 17, 2011 By Leave a Comment

Journal of Medical Virology Christine Mant, Barbara Kell, Philip Rice, Jennifer M. Best, Jon M. Bible, John Cason Article first published online: 6 OCT 2003 DOI: 10.1002/jmv.10529 Keywords: HPV-16; children; transient exposure Abstract High-risk human papillomaviruses, such as type 16 (HPV-16), are established etiological agents for cervical carcinoma. In most cases, this virus is transmitted sexually, [...]

[Continue reading...]
Filed Under: Cervical Cancer HPV, Clinical Trials, HPV Testing, STD's, Vaccine Science Tagged With: , , , ,